Assi T - Search Results

1

Evaluation of chronic kidney disease in cancer patients: is there a preferred estimation formula?

Sleilalty G, El Rassy E, Assi T, Al Rassy N, Nasseh J, Rizkallah J, Finianos S, Azar H, Chelala DN, El Karak F, Kattan J, Ghosn M. Sleilalty G, et al. Among authors: assi t. Intern Med J. 2018 Nov;48(11):1382-1388. doi: 10.1111/imj.13933. Intern Med J. 2018. PMID: 29660234

2

Overview on the role of preoperative therapy in the management of kidney cancer.

Assi T, El Rassy E, Farhat F, Kattan J. Assi T, et al. Clin Transl Oncol. 2020 Jan;22(1):11-20. doi: 10.1007/s12094-019-02136-5. Epub 2019 May 29. Clin Transl Oncol. 2020. PMID: 31144210 Review.

3

Treatment of cancer patients in their last month of life: aimless chemotherapy.

Assi T, El Rassy E, Tabchi S, Ibrahim T, Moussa T, Chebib R, El Karak F, Farhat F, Chahine G, Nasr F, Ghosn M, Kattan J. Assi T, et al. Support Care Cancer. 2016 Apr;24(4):1603-8. doi: 10.1007/s00520-015-2959-3. Epub 2015 Sep 21. Support Care Cancer. 2016. PMID: 26391890

4

Is minimal residual disease a convincing tool to determine the treatment duration of immune checkpoint inhibitors?

El Rassy E, Assi T, Kattan J. El Rassy E, et al. Among authors: assi t. Future Oncol. 2017 Feb;13(5):381-383. doi: 10.2217/fon-2016-0462. Epub 2016 Nov 25. Future Oncol. 2017. PMID: 27884060 No abstract available.

5

An unexpected response to second line EGFR inhibitor in relapsing leptomeningeal carcinomatosis from lung adenocarcinoma raises questions on differential mechanisms of action of these agents.

Ghosn M, Assi T, El Rassy E, Moussa T, Kattan J. Ghosn M, et al. Among authors: assi t. Bull Cancer. 2017 Apr;104(4):385-387. doi: 10.1016/j.bulcan.2016.12.006. Epub 2017 Jan 26. Bull Cancer. 2017. PMID: 28131317 No abstract available.

6

Could the combination of Nab-paclitaxel plus gemcitabine salvage metastatic pancreatic adenocarcinoma after folfirinox failure? A single institutional retrospective analysis.

El Rassy E, Assi T, El Karak F, Ghosn M, Kattan J. El Rassy E, et al. Among authors: assi t. Clin Res Hepatol Gastroenterol. 2017 Mar;41(2):e26-e28. doi: 10.1016/j.clinre.2016.11.012. Epub 2017 Feb 17. Clin Res Hepatol Gastroenterol. 2017. PMID: 28215539 No abstract available.

7

The Therapeutic use of human albumin in cancer patients' management.

Moujaess E, Fakhoury M, Assi T, Elias H, El Karak F, Ghosn M, Kattan J. Moujaess E, et al. Among authors: assi t. Crit Rev Oncol Hematol. 2017 Dec;120:203-209. doi: 10.1016/j.critrevonc.2017.11.008. Epub 2017 Nov 20. Crit Rev Oncol Hematol. 2017. PMID: 29198333 Review.

8

Efficacy and safety of everolimus in hormone receptor positive breast cancer in a developing country: Real-life single institutional experience.

Assi T, Kattan J, El Rassy E, Tabchi S, Chebib R, Moussa T, Hanna C, El Karak F, Farhat F, Ghosn M. Assi T, et al. J Cancer Res Ther. 2018 Jul-Sep;14(5):1112-1116. doi: 10.4103/0973-1482.183552. J Cancer Res Ther. 2018. PMID: 30197358 Free article.

9

Causes of death in older patients with cancer: Experience of a tertiary care center in Lebanon.

Assi T, Bakouny Z, Labaki C, El Rassy E, Khazzaka A, Jabbour R, Haddad FG, Tohme A, El Karak F, Ghosn M, Kattan J. Assi T, et al. J Geriatr Oncol. 2019 Mar;10(2):365-367. doi: 10.1016/j.jgo.2018.10.017. Epub 2018 Oct 31. J Geriatr Oncol. 2019. PMID: 30391115 No abstract available.

10

Beyond first-line systemic treatment for metastatic urothelial carcinoma of the bladder.

El Rassy E, Assi T, Bakouny Z, Pavlidis N, Kattan J. El Rassy E, et al. Among authors: assi t. Clin Transl Oncol. 2019 Mar;21(3):280-288. doi: 10.1007/s12094-018-1935-z. Epub 2018 Sep 4. Clin Transl Oncol. 2019. PMID: 30182210 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters